IMPROVED KIDNEY ALLOGRAFT SURVIVAL FOLLOWING REPEATED ANTI-REJECTION THERAPY IN PATIENTS WITH ANTIBODY-MEDIATED REJECTION AND PERSISTENT MICROVASCULAR INFLAMMATION UNDER ACTIVE HISTOLOGICAL SURVEILLANCE

 

Certificate Output Instructions

For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".

To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".

 

 

Certificate Background

   

Presented the abstract " "
(Abstract co-author(s):  )

 

 

  Back
E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center. 

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

​E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.​

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos
https://storage.unitedwebnetwork.com/files/1099/d975cfd7d0e1903b93f37a1118f0a16f.pdf
IMPROVED KIDNEY ALLOGRAFT SURVIVAL FOLLOWING REPEATED ANTI-REJECTION THERAPY IN PATIENTS WITH ANTIBODY-MEDIATED REJECTION AND PERSISTENT MICROVASCULAR INFLAMMATION UNDER ACTIVE HISTOLOGICAL SURVEILLANCE

Please follow the instructions below to input your abstract title.

Abstract titles should be brief and reflect the content of the abstract.

  • The title will not be accepted if it exceeds 25 words.
  • Type in CAPITAL LETTERS.
  • Lowercase may be used for abbreviations only, for example, mRNA.
Erick Yasar
Zuñiga Gonzalez
Erick Yasar Zuñiga Gonzalez yasareyzg@gmail.com Instituto Nacional de Ciencias Medicas y Nutrición Salvador Zubirán Department of Nephrology and Mineral Bone Metabolism Mexico City Mexico *
Luis Agustin Camacho Murillo luiscamachomurillo@gmail.com Instituto Nacional de Ciencias Medicas y Nutrición Salvador Zubirán Department of Nephrology and Mineral Bone Metabolism Mexico City Mexico -
Norma Ofelia Uribe Uribe nofeliauribe@yahoo.com.mx Instituto Nacional de Ciencias Medicas y Nutrición Salvador Zubirán Department of Pathology Mexico City Mexico -
Lluvia Aurora Marino Vazquez lluvia.marino@gmail.com Instituto Nacional de Ciencias Medicas y Nutrición Salvador Zubirán Department of Nephrology and Mineral Bone Metabolism Mexico City Mexico -
Luis Eduardo Morales Buenrostro luis_buenrostro@yahoo.com Instituto Nacional de Ciencias Medicas y Nutrición Salvador Zubirán Department of Nephrology and Mineral Bone Metabolism Mexico City Mexico -